Contact Us

Get 30% Free Customization on This Report

Published Date: June, 2019

Immuno Oncology Assays Market (Product - Consumables, and Software; Technology - PCR, Immunoassay, NGS, Flow Cytometry, and Other Technology; Indication - Lung Cancer, Colorectal Cancer, Melanoma, Bladder Cancer, and Other Indication; Application - Research Applications, and Clinical Diagnostics): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on immuno oncology assays market provides in-depth analysis of segments and sub-segments in the global as well as regional immuno oncology assays market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional immuno oncology assays market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global immuno oncology assays market. According to the report, the global immuno oncology assays market is projected to grow at a CAGR of 8.6% over the forecast period of 2019-2025.

 

Market Insight

Immune oncology is an area of medical research, which investigate how a body’s own immune system can fight cancer. Immuno oncology assay helps to determine the patient cancer condition during the cancer treatment. Further, it helps to determine the patient’s suitability to immunotherapy. These tests help to stimulate the immune system to treat cancer and enhance the immune of the body to combat cancer. As per the World Health Organization’s estimation, 9.6 million people died worldwide in 2018. It cost around USD 1.16 trillion to the global economy. Around 30-50% of cancers can be prevented with the help of better testing and treatment of the patients. Cancer is the second leading cause of death globally. As per the World Health Organization’s estimation, around 70% of death from cancer occur in low and middle-income countries. Further, the most common form of cancers in 2018 were lung (2.9 million cases), breast (2.09 million cases), colorectal (1.80 million cases), prostate (1.28 million cases), skin cancer (non-melanoma, 1.04 million cases) and stomach (1.03 million cases). Additionally, these cancerous diseases were the major common causes of cancer death around the world in 2018. The early diagnosis of cancer helps to save patients through better medication and treatment. Modern immune oncology assay helps to detect early symptoms of the cancer problem inside the human and helps to get better treatment.

 

The growing use of tobacco in different form as cigarettes, e-cigarette and smokeless tobacco is the leading cause of the cancer problem. Further, an unhealthy diet with low fruit and vegetable intake, lack of physical exercise, excessive alcohol consumption is the other factors for the growth of the immune-oncology assay market. As per the World Health Organisation, the tobacco use is the single major factor for the cancer problem and it is responsible for around 22% of cancer-related death globally.

 

North America is the leading region of the immune-oncology assay market, owing to the presence of the large patient pool in this region. Additionally, the availability of the several immune-oncology assay service providing healthcare companies is helping to maintain the leading position of this region in the global market. Europe is the second largest market after North America for immune-oncology assay market. The Asia-Pacific immune-oncology assay market is expected to grow at the highest CAGR during the forecast period, owing to the government support and dedication to pervade modern cancer treatment and testing facilities to its citizens at the affordable cost.

 

Segment Covered

The report on global immuno oncology assays market covers segments such as product, technology, indication, and application. On the basis of product, the sub-markets include consumables, and software. On the basis of technology, the sub-markets include PCR, immunoassay, NGS, flow cytometry, and other technology. On the basis of indication, the sub-markets include lung cancer, colorectal cancer, melanoma, bladder cancer, and other indication. On the basis of application, the sub-markets include research applications, and clinical diagnostics.

 

Companies Profiled:

The report provides profiles of the companies in the market such as PerkinElmer, Inc., HTG Molecular Diagnostics, Inc., Foundation Medicine, Inc., Sartorius AG, NanoString Technologies, Inc., Agilent Technologies, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Illumina, Inc, and QIAGEN GmbH.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of immuno oncology assays market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter